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Abstract   23 
Candida auris is an enigmatic yeast that provides substantial global risk in 24 
healthcare facilities and intensive care units. A unique phenotype exhibited by 25 
certain isolates of C. auris is their ability to form small clusters of cells known as 26 
aggregates, which have been to a limited extent described in the context of 27 
pathogenic traits. In this study, we screened several non-aggregative and 28 
aggregative C. auris isolates for biofilm formation, where we observed a level of 29 
heterogeneity amongst the different phenotypes. Next, we utilised an RNA 30 
sequencing approach to investigate the transcriptional responses during biofilm 31 
formation of a non-aggregative and aggregative isolate of the initial pool. 32 
Observations from these analyses indicate unique transcriptional profiles in the two 33 
isolates, with several genes identified relating to proteins involved in adhesion and 34 
invasion of the host in other fungal species. From these findings we investigated for 35 
the first time the fungal recognition and inflammatory responses of a three-36 
dimensional skin epithelial model to these isolates. In these models, a wound was 37 
induced to mimic a portal of entry for C. auris. We show both phenotypes elicited 38 
minimal response in the model minus induction of the wound, yet in the wounded 39 
tissue both phenotypes induced a greater response, with the aggregative isolate 40 
more pro-inflammatory. This capacity of aggregative C. auris biofilms to generate 41 
such responses in the wounded skin highlights how this opportunistic yeast is a high 42 
risk within the intensive care environment where susceptible patients have multiple 43 






Candida auris has recently emerged as an important cause of concern within 48 
healthcare environments due to its ability to persist and tolerate commonly used 49 
antiseptics and disinfectants, particularly when surface attached (biofilms). This 50 
yeast is able to colonise and subsequently infect patients, particularly those that are 51 
critically ill or immunosuppressed, which may result in death. We have undertaken 52 
analysis on two different phenotypic types of this yeast, using molecular and 53 
immunological tools to determine whether either of these has a greater ability to 54 
cause serious infections. We describe that both isolates exhibit largely different 55 
transcriptional profiles during biofilm development. Finally, we show that the inability 56 
to form small aggregates (or clusters) of cells has an adverse effect on the 57 
organisms immuno-stimulatory properties, suggestive the non-aggregative 58 
phenotype may exhibit a certain level of immune evasion. 59 
Introduction 60 
C. auris is a nosocomial pathogen first identified in 2009 (1). To date, this multidrug 61 
resistant organism has been identified in over 40 countries on 6 different continents, 62 
providing a substantial global risk in healthcare facilities and intensive care units (2-63 
4). It is postulated that the emergence of C. auris may have coincided with climate 64 
change based on its particular attributes, resulting in an thermotolerant organism 65 
with the ability to persist in the environment before transmission to humans (5).  66 
A unique pathogenic trait exhibited by some isolates of C. auris is their ability to form 67 
aggregates (Agg) (6-8). Despite the well-documented prevalence of C. auris 68 
worldwide, relatively little is known about the Agg phenotype of the organism. The 69 
existence of four geographically and phylogenetically distinct clades of the organism 70 
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(2), and a fifth recently proposed (9), has restricted a definitive profiling of C. auris 71 
pathogenic mechanism of these aggregates in regard to biofilm forming capabilities, 72 
drug resistance pathways and interactions with the host. Of the publications that 73 
exist, these have documented characteristic pathogenic traits for both phenotypes in 74 
vitro and in vivo (6, 10, 11). Others have shown that the Agg phenotype is inducible 75 
under certain conditions (7, 8), whilst histological analyses of murine models have 76 
shown that aggregates can accumulate in organs following C. auris infection (7, 12, 77 
13). Therefore, further studies are required to investigate this characteristic Agg 78 
phenomenon in C. auris isolates to fully comprehend the pathogenic pathways of the 79 
organism, and to understand how such mechanisms may differ from their non-Agg 80 
counterparts. 81 
Limited evidence also exists for studies investigating the interactions of C. auris with 82 
components of the host, although several in vivo models have been employed to 83 
document the virulence of C. auris. Of these, Galleria mellonella larvae infection 84 
models and murine models of invasive candidiasis have shown varying survival rates 85 
post-infection with C. auris (6, 8, 10, 12-15), reaffirming that genetic variability 86 
amongst clades impacts the organisms virulence. However, such studies have been 87 
limited in investigating the host immune response to the organism. Recently, 88 
Johnson et al (2019) utilised a Zebrafish (Danio rerio) model to monitor C. auris-host 89 
cell interactions in vivo. This work highlighted that C. auris (strain B11203 Indian 90 
isolate phylogenetically part of the South Asian or India/Pakistan clade (2), which 91 
appeared to exhibit a non-Agg phenotype) was resistant to neutrophil-mediated 92 
killing, suggesting that the organism has the ability to persist incognito in the host 93 
(16). In vitro studies have shown interactions between C. auris and epithelial tissue, 94 
emphasizing that the organism can persist on skin. In this study, Horton and 95 
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colleagues (2020) demonstrated that C. auris (B11203 strain, as above) formed 96 
high-burden biofilms on porcine skin biopsies in the presence of an artificial sweat 97 
medium (17). However, to date, no studies have documented the host inflammatory 98 
response to the non-Agg and/or Agg phenotype.  99 
In this study, we sought to investigate the level of heterogeneity amongst different 100 
non-Agg and Agg isolates. We deemed this pertinent given that such traits of 101 
heterogeneity amongst isolates have previously been described for other Candida 102 
species, significantly impacting clinical outcomes and mortality rates (18). To further 103 
investigate this Agg versus non-Agg phenotype, transcriptome analyses were 104 
performed on planktonic cells and biofilms of two selected isolates from the initial 105 
pool. Upon completion of these analyses, we discovered that several genes 106 
associated with cell membrane and/or cell wall proteins (e.g. cellular components) 107 
were upregulated in the Agg biofilm. Such unique transcriptional profiles in respect to 108 
the cellular components led us to investigate the host response following stimulation 109 
with both C. auris phenotypes in vitro. For this, a two- and three-dimensional skin 110 
wound model was employed to investigate the epithelial response to the Agg and 111 
non-Agg isolates of C. auris. Both skin wound models exhibited different profiles to 112 
each isolate indicating unique fungal recognition and/or host response to the Agg 113 
and non-Agg phenotype. Interestingly, there was minimal response by the host to C. 114 
auris without induction of the wound, suggestive the organism relies on loss of tissue 115 
integrity to become invasive.    116 
Methods  117 
Microbial growth and standardisation 118 
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For in vitro biofilm biomass assessment, a pool of aggregating (Agg; n=12) and 119 
single-celled, non-aggregative (non-Agg; n=14) C. auris clinical isolates (gifted by Dr 120 
Andrew Borman and Dr Elizabeth Johnson, Public Health England, UK). The isolates 121 
used and the clades they belong to are shown in Table 1. All C. auris isolates were 122 
stored in MicrobankTM beads (Pro-lab Diagnostics, UK) prior to use. Each isolate was 123 
grown on Sabouraud dextrose (SAB) agar (Oxoid, UK) at 30˚C for 24-48 h then 124 
stored at 4˚C prior to propagation in yeast peptone dextrose (YPD; Sigma-Aldrich, 125 
UK) medium overnight (16 h) at 30˚C, gently shaking at 200 rpm. Cells were pelleted 126 
by centrifugation (3,000 x g) then washed two times in phosphate buffered saline 127 
(PBS). Cells were then standardised to desired concentration following counting 128 
using a haemocytometer, then resuspended in selected media for each assay, as 129 
described within.  130 
C. auris isolate phenotypes were determined visually by suspending one colony in 1 131 
mL (PBS, Sigma-Aldrich, UK). Isolates were termed as ‘aggregators’ if the added 132 
colony did not disperse upon mixing in PBS. For RNA sequencing and transcriptional 133 
analysis of C. auris biofilms and co-culture systems, one Agg (NCPF 8978) and non-134 
Agg (NCPF 8973) isolate was used.  135 
 136 
Biofilm growth and biomass assessment 137 
Fungal cells were adjusted to 1 x 106 cells/mL in Roswell Parks Memorial Institute 138 
(RPMI) media (Sigma-Aldrich, UK) and biofilms formed for 4 or 24 hours at 37˚C in 139 
flat-bottom wells of 96-well plates (Corning, UK). Appropriate media controls were 140 
included on each plate to test for contamination. Following incubation, biofilms were 141 
washed gently once in PBS to remove any non-adhered cells. The biomass of each 142 
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biofilm was determined via 0.05% crystal violet (CV) staining as described previously 143 
(19). Absorbance of the CV stain was measured spectrophotometrically at 570nm in 144 
a microtiter plate reader (FLUOStar Omega, BMG Labtech, UK).  145 
 146 
Monitoring the growth of Candida auris biofilms in real time 147 
The xCELLigence real time cell analyser (RTCA, ACEA Bioscience Inc, San Diego, 148 
CA) was used to monitor the formation of C. auris biofilms in real time using electron 149 
impedance measurements (presented as cell index, CI) which is directly related to 150 
cell attachment and proliferation. In brief, the E-plate containing 100 µL of pre-heated 151 
RPMI medium was loaded into the RTCA which had been placed in the incubator 2 h 152 
prior to the experiment to test media impedance and electrode connectivity. Cultures 153 
of each C. auris isolate used in this study were standardised to 2 x 106 CFU/mL and 154 
added to the E-plate in 100 µL aliquots in triplicate. Appropriate media controls 155 
minus inoculum were also included in triplicate. Biofilm formation was measured over 156 
24 hours with CI readings taken every 5 minutes. Normalised CI values were 157 
exported from the RTCA software and analysed in GraphPad Prism (version 8; 158 
GraphPad Software Inc., La Jolla, CA). More detailed descriptions for this technology 159 
can be found elsewhere (20). 160 
 161 
Two-dimensional monolayer co-culture model 162 
Adult human epidermal keratinocytes (HEKa) cells (Invitrogen, GIBCO®, UK) were 163 
used for two-dimensional co-culture experiments. Frozen stocks of HEKa cells (1 x 164 
106 cells/ml; passage number lower than 10) were revived and seeded in T-75 tissue 165 
culture flasks (Corning, UK) in media 154 (Thermo-Fisher, UK) supplemented with 166 
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100 U/ml of pen/strep and human keratinocyte growth supplement (HKGS) (Thermo-167 
Fisher, UK). The flasks were incubated at 37°C (5 % CO2) and media was changed 168 
every 48 h until the cells reached 80-90% confluence (21). Confluent cells were 169 
passaged using 0.05% trypsin EDTA (Sigma-Aldrich, UK) and the enzymatic 170 
reaction inhibited using trypsin neutralizer solution (Sigma-Aldrich, UK). Passaged 171 
cells were then seeded into 24-well plates (Corning, UK) at final concentration 2 x 172 
105 cells/ml. After 24 to 48 h the cells reached the adequate confluence for C. auris 173 
co-culture experiments as described below.  174 
 175 
Three-dimensional human epidermis co-culture model 176 
Reconstituted human epidermis (RHE) used for 3D co-culture experiments was 177 
purchased from Episkin (Skin Ethic™, Lyon, France http://www.episkin.com). RHE 178 
was formed from normal human keratinocytes cultured on an inert polycarbonate 179 
filter at the air-liquid interface, in a chemically defined medium grown to 17-day 180 
maturity. This model is histologically similar to in vivo human epidermis. Upon arrival 181 
and prior to experimental set-up, RHE was incubated with maintenance media in 24-182 
well plates (Corning, UK) for 24 h, 5% CO2 at 37
oC. Maintenance media was 183 
replaced then the co-culture three-dimensional system was set up as described 184 
below.    185 
 186 
Wound model in two-dimensional and three-dimensional co-culture systems 187 
HEKa cell monolayers were scratched using a similar method to as previously 188 
described to mimic a wound model (22, 23). Briefly, monolayers were grown to 189 
confluence as described above then three parallel scratches were introduced across 190 
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the surface using a 100 μL pipette tip prior to inoculation with C. auris. For RHE, a 191 
19-gauge needle was used to scratch the tissue. For all co-culture experiments, Agg 192 
C. auris NCPF 8978 and non-Agg C. auris NCPF 8973 were grown as described 193 
above, then standardised to 2 x 106/mL (multiplicity of infection of 10 to HEKa cells; 194 
MOI 10, and as previously described for Candida-tissue co-culture (24)). For the two-195 
dimensional system, 2 x 106/mL C. auris was prepared in 500µL supplemented 196 
media 154 and added directly to the confluent HEKa cells. For the three-dimensional 197 
co-culture model, 2 x 106/mL C. auris was prepared in 100µL of sterile PBS and this 198 
suspension was added directly to the RHE tissue. All experiments were conducted 199 
for 24 hr at 5% CO2. Infected non-scratched HEKa cells and RHE tissue were used 200 
as controls e.g., no wound, and uninoculated co-cultured cells or tissues were also 201 
included for all experiments. All control and wounded models were infected in 202 
triplicate with both isolates of C. auris.  203 
 204 
Histological staining of skin epidermis 205 
Following co-culture with C. auris, epithelial tissue was carefully cut from the 0.5 cm2 206 
insert using a 19-gauge needle and washed three times in sterile PBS to remove 207 
non-adherent cells in a similar manner as previously described (25), as summarized 208 
in the schematic in Figure 1. Tissue was then fixed in 10% neutral-buffered formalin 209 
prior to embedding in paraffin. A Finnesse ME+ microtome (Thermo Scientific, UK) 210 
was used to cut 2 μm sections and tissue sections stained with haematoxylin and 211 
eosin, or with the fungal specific Periodic acid-Schiff (PAS) reagents and counter-212 




Epithelial cell viability 215 
To assess any cytotoxic effects of C. auris on HEKa cells and RHE tissue, a Pierce 216 
lactate dehydrogenase (LDH) Cytotoxicity Assay Kit (Thermo Scientific; UK) was 217 
used according to the manufacturers’ instructions. Following co-culture, cell or tissue 218 
spent media was assayed using the above kit to quantify the level of LDH release as 219 
a measure of host cellular disruption.   220 
 221 
Differential gene expression analysis  222 
HEKa cells and RHE tissue following co-culture were lysed in RLT lysis buffer 223 
(Qiagen Ltd, UK) containing 0.01% (v/v) β-2-mercaptoethanol (β2ME) before bead 224 
beating. All RNA was extracted using the RNeasy Mini Kit according to 225 
manufacturers’ instructions (Qiagen Ltd, UK) and quantified using a NanoDrop 1000 226 
spectrophotometer [Thermo Scientific, UK]. RNA was converted to complementary 227 
DNA (cDNA) using the High Capacity RNA to cDNA kit (Life Technologies, UK) as 228 
per the manufacturer’s instructions. Gene expression was assessed using SYBR 229 
GreenER based-quantitative polymerase chain reaction (qPCR) or RT2 profiler arrays 230 
(Qiagen Ltd, UK). For SYBR GreenER based-qPCR analyses, the following PCR 231 
thermal profiles was used; holding stage at 50˚C for 2 minutes, followed by 232 
denaturation stage at 95˚C for 10 minutes and then 40 cycles of 95˚C for 3 seconds 233 
and 60˚C for 15 seconds. qPCR plates were run on the StepOnePlus™ Real-Time 234 
PCR System. The following primer sequences were used for SYBR GreenER based-235 
qPCR analyses of host cells; GAPDH, forward primer, 5’ to 3’, 236 
CAAGGCTGAGAACGGGAAG and reverse primer, 5’ to 3’, 237 
GGTGGTGAAGACGCCAGT (26); IL8, forward primer, 5’ to 3’, 238 
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CAGAGACAGCAGAGCACACAA and reverse primer, 5’ to 3’, 239 
TTAGCACTCCTTGGCAAAAC (27). For gene expression analyses of C. auris, 240 
primers for adhesin gene ALS5 and proteinase gene SAP5 were used as follows; 241 
ALS5;  forward primer, 5’ to 3’, ATACCAGGGTCGGTAGCAGT and reverse primer, 242 
5’ to 3’, CTATCTTCGCCGCTTGGGAT and SAP5; forward primer, 5’ to 3’,  243 
GGATGCAGCTCTTCCTGGTT and reverse primer, 5’ to 3’, 244 
CTTCCAGTTTGCGGTTGTGG. For other gene expression analyses of RHE tissue, 245 
a custom designed RT2 Profiler PCR array was compiled containing primers for 246 
genes associated with inflammation and fungal recognition or stimulation of host 247 
tissue. For these arrays, the following thermal cycle was used on the MxProP 248 
Quantitative PCR machine; 10 minutes at 95oC followed by 40 cycles of 15 seconds 249 
at 95oC and 60 seconds at 60oC, and data assembled using MxProP 3000 software 250 
(Stratagene, Netherlands). Expression levels for all genes of interest were 251 
normalized to the housekeeping gene, β-actin for C. auris gene expression and 252 
GAPDH for mammalian cells, according to the 2-ΔCt method, and then quantified 253 
using the 2-ΔΔCt method (28).  254 
 255 
RNA sequencing  256 
For RNA sequencing of C. auris biofilms, RNA was extracted from 24-h C. auris 257 
biofilms as described previously (29). In brief, biofilms were grown as above on 258 
Thermanox coverslips (Thermo-Fisher, UK) in 24 well plates (Corning, UK). Biofilms 259 
were removed from coverslips by sonication at 35 kHz for 10 minutes in a sonic bath 260 
in 1 ml of PBS and the sonicate transferred to a 2.0 ml RNase-free bead beating 261 
tube (Sigma-Aldrich, UK). Cells were homogenized in TRIzol ™ (Invitrogen, UK) with 262 
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0.5 mm glass beads using a BeadBug microtube homogeniser for a total of 90 263 
seconds (Benchmark-Scientific, USA). RNA was then extracted as described above 264 
using the RNeasy Mini Kit according to manufacturers’ instructions (Qiagen Ltd, UK).  265 
Following extraction, RNA quality and quantity were determined using a Bioanalyzer 266 
(Agilent, USA), where a minimum RNA integrity number and quantity of 7 and 2.5 µg, 267 
respectively were obtained for each sample. Annotation of data following sample 268 
submission to Edinburgh Genomics (http://genomics.ed.ac.uk/) was completed as 269 
previously described (30). Briefly, raw fastq reads were trimmed and aligned to the 270 
Candida auris representative genome B8441 using Hisat2 (31). Reads were then 271 
processed and assembled de novo using the Trinity assembly pipeline (32). 272 
Trinotate and Blast2Go were utilised to assign gene IDs to homologous sequences 273 
using BLAST and Interpro (33, 34). Differential expression analysis was performed 274 
according to DESeq2 pipeline and functional over representation was determined 275 
using GOseq (35, 36) within R. All transcriptional analyses reported for one isolate 276 
were calculated in reference to the other isolate, and vice versa. Additionally, 277 
visualisation of overrepresented pathways were drawn within R. Raw data files for 278 
these analyses are deposited under accession no. PRJNA477447. 279 
 280 
Statistical analysis 281 
Statistical analyses were performed using GraphPad Prism. Two-tailed paired or 282 
unpaired Student’s t-tests were used to compare the means of two samples as 283 
stated within, or one-way analysis of variance (ANOVA) to compare the means of 284 
more than two samples. Tukey’s post-test was applied to the p value to account for 285 
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The Agg phenotype is a unique trait of C. auris, one that can influences the 291 
organisms pathogenic traits in vitro and in vivo (6, 10, 11). To corroborate these 292 
previous observations, differences in early and late biofilm formation were assessed 293 
between non-Agg and Agg isolates of C. auris. A total of 26 non-Agg and Agg C. 294 
auris clinical isolates were screened during early (4 h) and mature (24 h) biofilm 295 
growth stages (Figure 2A and B). Both sets of non-Agg and Agg C. auris isolates 296 
formed biofilms in a time-dependant manner as assessed by crystal violet staining. 297 
With the exception of NCPF 8993 (non-Agg) and NCPF 8996 (Agg), all isolates 298 
formed biofilms with greater biomass after 24 hours culture compared to 4 hours 299 
(Figure 2C and D). Although, the Agg phenotype tended to form biofilms with greater 300 
biomass at both 4 h and 24 h, we observed no statistical differences when 301 
collectively comparing all non-aggregating and aggregating isolates of C. auris at 302 
either timepoint (Supplementary Figure 1A and B). From this data, it was clear that 303 
some isolates formed biofilms with greater biomass than others, suggestive of a 304 
certain level of heterogeneity between isolates of Agg and non-Agg phenotype, in 305 
line with previous observations (6, 10, 37). Similar trends of biofilm heterogeneity 306 
were observed when monitoring biofilm formation via impedance measurements in 307 
real time at both timepoints in non-Agg and Agg phenotype (Figure 2E-H and 308 
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Supplementary 1C and D). These data support corroboration of these unique 309 
phenotypes amongst isolates.  310 
To further study the pathogenic and biofilm-forming characteristics of Agg and non-311 
Agg C. auris, transcriptional profiling of 24-hour planktonic vs biofilm phenotypes 312 
was performed. For these studies, two clinical isolates from the initial pool tested 313 
were selected for analysis (non-Agg NCPF 8973 and Agg NCPF 8978, indicated by 314 
the red points in Figure 2). Firstly, we found that a total of 701 genes were 315 
upregulated in planktonic and/or biofilm form of Agg compared to the non-Agg 316 
phenotype, of which 450 genes were upregulated in the biofilm state (Figure 3A). 317 
Conversely, less genes (430) were upregulated in non-Agg C. auris in the planktonic, 318 
biofilm or both states compared to Agg C. auris counterparts, with 194 genes up-319 
regulated in the biofilm form (Figure 3B). In order to understand the functional 320 
processes related to differentially expressed genes, a cut-off of 2-fold up-regulation 321 
was used for gene ontology (GO) analysis (adjusted P value of < 0.05). Up-regulated 322 
genes in non-Agg vs. Agg C. auris biofilms normalized to planktonic cell expression 323 
involved three functional classes; biological processes (BP), cellular components 324 
(CC) and metabolic functions (MF) (Supplementary Figure 2A and B). Interestingly, 325 
most genes upregulated in the Agg biofilm belonged to the CC functional class; over 326 
40 genes related to membrane and cell wall constituents were upregulated in the 327 
Agg form compared to the non-Agg phenotype (Figure 3C). Several genes 328 
associated with fungal cell wall proteins were upregulated in the Agg biofilms 329 
including TSA1, ECM33, MP65 and PHR1 (Supplementary Figure 2C). Moreover, 330 
included in these 40 genes were members of the ALS family of adhesins such as 331 
ALS1. On the contrary, in the non-Agg biofilms, the greatest changes in expression 332 
were observed for genes belonging to functional classes of BP and MF 333 
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(Supplementary Figure 2C). Only a small number of genes belonging to cellular 334 
components were upregulated in the non-Agg compared to Agg biofilm (Figure 3D). 335 
Of these, <20 genes belonging to the peroxisome, glycine cleavage complex, myelin 336 
sheath and glyoxysome were upregulated in the non-Agg isolate.  337 
The observed differences in the transcriptional profiles of genes belonging to the CC 338 
of C. auris could impact the ability of the host to recognize the two phenotypes. For 339 
example, key cellular components such as ALS proteins of other Candida species, 340 
such as Candida albicans play important roles in aiding host colonization and 341 
orchestrating the innate immune response (38, 39). However, it is currently unknown 342 
whether similar mechanisms exist for C. auris. Therefore, the following section 343 
investigates whether a non-Agg or Agg phenotype dictates the response by the host 344 
to C. auris. For this, a two- and three-dimensional skin epithelial model was 345 
employed to study the host response to the two C. auris isolates used above. For 346 
both co-culture skin systems, a wound was induced to mimic the possible entry site 347 
of patients for C. auris in healthcare environments. In the two-dimensional model 348 
containing adult human epidermal keratinocytes (HEKa) cells, both isolates were 349 
significantly more cytotoxic to host cells following induction of the wound (Figure 4A; 350 
**** p < 0.001). Intriguingly, Agg C. auris was significantly more cytotoxic than non-351 
Agg form in the wound model (Figure 4A; §§ p < 0.01). It is noteworthy that wounded 352 
monolayers minus inoculum were comparable to untreated monolayers (data not 353 
shown), suggestive that induction of the wound did not induce cytotoxic effects on 354 
the cells. A similar trend in cytotoxicity was observed between the two isolates in the 355 
three-dimensional model (Episkin, SkinEthicTM reconstructed human epidermis; 356 
RHE) although this did not reach statistical significance (Figure 4B). Interestingly, 357 
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cytotoxicity of Agg and non-Agg C. auris were comparable in both co-culture models 358 
minus wounds.  359 
To further study the host response in the three-dimensional system, a transcriptional 360 
response in the tissue was investigated using a RT2 profiler array containing primers 361 
specific for genes associated with inflammatory responses and/or fungal recognition 362 
(Figure 4C). Upon investigation, it was evident that the greatest changes in gene 363 
expression were observed in the wound models for both C. auris isolates. 364 
Importantly, induction of the wound minus C. auris did not significantly alter the 365 
expression of any of the genes arrayed. In the wound model, pro-inflammatory 366 
cytokines TNFα and IL1β (* p<0.05) were significantly upregulated in RHE tissue 367 
cultured with non-Agg C. auris. Conversely, the Agg phenotype of C. auris induced 368 
the greatest changes in RHE; the expression of 8 of the 11 genes profiled (IL1β, 369 
*p<0.05; TNF, IL6, CAMP, ** p<0.01; CFS2, CFS3, CLEC7A, *** p<0.001; TLR4, **** 370 
p<0.0001) were all significantly upregulated following co-culture compared to the 371 
untreated tissue.  372 
In the three-dimensional co-culture system, it was evident from histological and 373 
fungal specific Periodic acid-Schiff (PAS) staining that the both isolates of C. auris 374 
had adhered to the peripheral keratinised layer of the RHE tissue (Supplementary 375 
Figure 3). Uninfected tissue displayed a well-organized multi-layered structure 376 
characteristic of skin epidermis in vivo (40) (Supplementary Figure 3A). However, in 377 
infected tissue, there was no sign of C. auris infiltration into the tissue 378 
(Supplementary Figure 3A and B) as seen with previous publications of skin tissue 379 
infection models with invasive C. albicans (24, 41). Unfortunately, loss of tissue 380 
integrity in the wounded model rendered them unsuitable for histological staining 381 
therefore at this juncture we were unable to visualize whether C. auris invaded the 382 
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tissue at the wound site. Nonetheless, given that the expression of several important 383 
cell membrane and wall proteins are differentially regulated in non-Agg and Agg 384 
phenotypes of C. auris biofilms, we wanted to assess the gene response in C. auris 385 
infected on the tissue. For this, two key virulence factor genes belonging to the ALS 386 
and SAP families, respectively, were selected for analyses. Both these gene families 387 
are involved in translation of two key proteins associated with Candida invasion of 388 
the host and associated virulence (42-44). The two genes selected, ALS5 and SAP5, 389 
were both up-regulated in the Agg phenotype compared to the non-Agg C. auris 390 
isolate in the three-dimensional tissue model (Figure 4D and 4E). Such a response 391 
in the Agg isolate may begin to elucidate the mechanism by which this phenotype 392 
generated a greater inflammatory response within the tissue.    393 
 394 
Discussion  395 
Results from this study further indicates that the Agg phenotype of C. auris 396 
determines its pathogenicity in vitro. This phenotype, first reported by Borman et al 397 
(2016), is by characterised in certain isolates by the formation of individual yeast 398 
cells mixed with large aggregations in planktonic form (6). This aggregating 399 
behaviour was later shown to affect biofilm formation, antifungal susceptibility and 400 
virulence of the organism (6, 10, 11, 37). Moreover, aggregation has recently been 401 
found to be an inducible trait triggered by sub-inhibitory concentrations of triazole 402 
and echinocandin antifungals, suggestive that treatment regimens must be carefully 403 
considered to combat C. auris dependant on its Agg phenotype (8). In this study, we 404 
report a previously described RNA-sequencing approach (30) in order to compare 405 
the transcriptional responses of one non-Agg (NCPF 8973) and one Agg (NPCF 406 
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8978) isolate of C. auris during formation of biofilms from planktonic cells. These 407 
analyses indicated that several key cell membrane and cell wall components were 408 
upregulated in Agg biofilms, many of which involved in cell adhesion to abiotic 409 
surfaces and host cells. These observations led us to pose the question: how would 410 
the host respond to the two phenotypes? As such, we document for the first time an 411 
investigation into the host skin epithelial response to Agg and non-Agg C. auris.   412 
Given the clear differences in virulence traits of the non-Agg and Agg phenotype, we 413 
deemed it pertinent to study in greater detail the transcriptional profiles of one non-414 
Agg and one Agg C. auris. These two isolates displayed the heterogeneity exhibited 415 
by other Agg and non-Agg isolates, with the NCPF 8973 isolate forming a denser 416 
biofilm after 24 h (as shown here in Figure 2 by the red data points, and elsewhere 417 
(10)). It must be noted here that the non-Agg C. auris isolates showed high variation 418 
in biofilm forming capabilities, with the NCPF 8973 isolate forming a biofilm with 419 
greater biomass than the other isolates in the group. On the contrary, the Agg isolate 420 
selected (NCPF 8978) was an intermediate biofilm former amongst its group.  421 
Nevertheless, irrespective of the biofilm-forming capabilities, transcriptome analyses 422 
showed that an increased number of genes were upregulated in the Agg compared 423 
to the non-Agg biofilm of the two selected (450 vs 194 genes, respectively; Figure 3), 424 
suggestive that the clustering of aggregated cells greatly impacts the transcriptome 425 
of the organism during the formation of a biofilm. Of these differential responses in 426 
the two biofilm phenotypes, a vast number of genes upregulated in the Agg biofilm 427 
belonged to CC as assessed using GO analyses Specifically, several cell wall genes 428 
were upregulated in the Agg phenotype e.g., TSA1, ECM33, MP65, ALS1 and 429 
PHR1. In C. albicans, ECM33 and MP65 have been implemented as important 430 
proteins in maintenance of fungal cell wall integrity, biofilm formation and stress 431 
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responses (45-47). Furthermore, the ALS family of adhesin proteins and PHR family 432 
of extracellular transglycosylases also function as important regulators of biofilm 433 
formation in C. albicans (48, 49). For example, loss of function of PHR and ALS 434 
proteins results in impaired adhesion and biofilm development (50, 51). It must be 435 
noted here that such direct comparisons in transcriptional responses between 436 
findings on C. auris and C. albicans biofilms must be taken with a certain degree of 437 
caution. This being so given the lack of true hyphal formation by C. auris isolates 438 
grown in biofilms (6), although such a trait can be induced under some conditions (7, 439 
14). An absence of hyphae in C. auris during biofilm formation could impact the 440 
transcriptional response by the organism when compared to other Candida species, 441 
especially given that proteins such as ALS have been shown to be upregulated and 442 
involved in the yeast-to-hyphae transition in C. albicans (52, 53).  Nevertheless, such 443 
in-depth analyses, as those documented herein, may begin to explain the 444 
mechanisms behind aggregate formation in biofilms of some C. auris isolates.  445 
Most of the aforementioned genes (TSA1, ECM33, MP65, ALS1 and PHR1) have 446 
multiple functions in C. albicans pathogenicity, particularly in biofilm formation as 447 
discussed above. In addition, most also play key roles in attachment and/or survival 448 
within the host in other fungal species. For example, TSA1, which encodes for a 449 
protein called thiol-specific antioxidant 1, has been identified in C. albicans and 450 
Cryptococcus neoformans, and functions as an important stress response regulator 451 
in unfavourable oxidative environments (54, 55); potentially those generated by the 452 
host (56). In C. albicans, ECM33, MP65 and PHR1 have been shown to be important 453 
genes necessary for production of proteins involved in adherence and invasion of 454 
host cells (45-47, 50). For example, in similar three-dimensional reconstituted skin 455 
and oral epithelial co-culture models, heterozygous mutants of ECM33 and PHR1 456 
 20 
 
displayed clear deficiencies in penetration of epithelial cell layers leading to reduced 457 
tissue invasion and subsequent cellular damage (46, 50). Finally, another gene 458 
upregulated in Agg C. auris biofilms was ALS1, a member of the ALS family of 459 
adhesin proteins. This cohort of adhesin proteins which contains at least 8 members 460 
in C. albicans are well documented virulence factors, particularly in host-pathogen 461 
interactions in vitro and in vivo (42, 48, 57). Concerning the results shown in this 462 
study, the role of ALS1, which encodes for the protein Als1p, in Candida-host 463 
interactions remains unclear. As such, contradictory reports state a role for this 464 
adhesion in attachment to epithelial cells. Kamai and colleagues (2002) showed that 465 
heterozygous knockouts of ALS1 were unable to colonize oral tissues of mice in vivo 466 
and ex vivo as efficiently as wildtype strains or knockouts coupled with the Als1p 467 
reinstated (58). On the contrary, it was shown that attachment of the C. albicans 468 
ALS1 null mutant to oral epithelial cells was no different than wildtype controls, 469 
suggestive its role in adhesion was not as important as other ALS family members 470 
(43). Nevertheless, as discussed briefly above, such comparisons between C. auris 471 
and C. albicans interactions with host cells must be tentatively compared given the 472 
differences in the morphological forms of the two species. In particular, the transition 473 
from yeast to hyphae in C. albicans is essential for tissue invasion of mucosal 474 
surfaces. For example, fungal invasion mechanisms have been identified that show 475 
morphological changes from yeast, to pseudohyphae, to hyphae during the process 476 
of adhesion and invasion in C. albicans in epithelial tissue (59, 60). This process is 477 
even essential for the discrimination of commensal and pathogenic forms of C. 478 
albicans by the host (61). Given its inability to form hyphae under normal 479 
physiological conditions, how C. auris can invade epithelial tissue is unknown. It is 480 
possible that the organism has different invasive mechanisms to other Candida 481 
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species, including possible variations amongst isolates from different clades. 482 
However, at this juncture, further studies are necessary to elucidate such 483 
mechanisms, including consideration of the virulence properties of various non-Agg 484 
and Agg isolates.  485 
It has been postulated that C. auris exhibits a level of immune evasion to bypass 486 
immunological defences (4). Recent work by Johnson et al (2019) showed that C. 487 
auris were resistant to neutrophil-mediated killing by failing to stimulate neutrophil 488 
elastase trap (NET) formation both in vitro and in vivo in a zebrafish infection model 489 
(16). Another study found that viable C. auris did not induce an inflammatory 490 
response in human peripheral blood mononuclear cells (PBMCs), although fungal 491 
cells were recognized and engulfed by human monocyte-derived macrophages. 492 
Conversely, such host responses were significantly greater against other Candida 493 
species such as Candida tropicalis, Candida guilliermondii and Candida krusei (62). 494 
It is apparent from these studies that the host recognizes yet fails to generate an 495 
effective immune response against C. auris. From the results described here, it is 496 
evident that C. auris is not cytotoxic nor pro-inflammatory to intact skin epithelial cells 497 
or epidermis tissue. Only following induction of a wound in these models did C. auris 498 
elicit any significant response by the host. From this, it could be suggested that 499 
under normal immunological conditions, the organism is non-invasive, and any 500 
immune response from the host is minimal. Confirming this, previous studies have 501 
shown that immunocompetent mice were more resistant to C. auris infection than 502 
immunocompromised mice (15). Such findings have been seen in humans; invasive 503 
C. auris infections generally occur in critically ill patients with serious underlying 504 
medical conditions resulting in haematological deficiencies and/or 505 
immunosuppression (63-65). These observations from animal models and human 506 
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studies are suggestive that an effective immune system is required to prevent C. 507 
auris infection. In the context of this study, the observed non-invasive phenotype of 508 
C. auris may simply be due to lack of hyphal formation, whereby yeast cells colonize 509 
the periphery of the skin yet do not invade the underlying layers unless in the 510 
presence of a wound. Indeed, similar observations have been made elsewhere. 511 
Horton et al (2020) recently showed that C. auris forms layers of cells on the 512 
periphery of porcine skin ex vivo, however, these structures of C. auris are devoid of 513 
pseudohyphae or hyphae (17). Until further studies commence, we cannot comment 514 
on whether the observed interactions with the host tissue are homogenous amongst 515 
the non-Agg and Agg phenotypes.  516 
A limitation from previous studies is the failure to investigate the host response to the 517 
Agg phenotype expressed by certain isolates. We and others have previously shown 518 
that the non-Agg isolate of C. auris are more virulent in G. mellonella larvae models 519 
than the Agg counterparts, possibly resulting from enhanced dissemination rates of 520 
the single cells (6, 10). Here, the Agg NCPF 8978 isolate was significantly more 521 
cytotoxic and pro-inflammatory than non-Agg NCPF 8973 in the two- and three- 522 
dimensional skin models. At this juncture it is unknown why such a response occurs 523 
in the host. Murine model of candidiasis have shown that C. auris can accumulate in 524 
the kidney of the mice in the form of aggregates (7, 12, 13), suggestive that 525 
aggregation may occur in vivo to enable persistence and survival. However, to date, 526 
no studies have investigated the host response to such C. auris aggregates in vivo. It 527 
could simply be that the Agg phenotype generates a cluster of cells with increased 528 
pathogenic traits to induce a greater host response than single cells. This was 529 
confirmed by the upregulation of two key adhesin and proteinase genes, ALS5 and 530 
SAP5, in the Agg NCPF 8978 isolate compared to non-Agg NCPF 8973 in the skin 531 
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epidermis model. Interestingly, similar observations have been described in biofilm-532 
dispersed single cells vs. aggregates in model bacteria such as Pseudomonas 533 
aeruginosa. As such, dispersed aggregates of P. aeruginosa possess enhanced 534 
antibiotic resistance traits, likely due to encapsulation by extracellular matrix, and 535 
greater immune evasion techniques over dispersed single cells (66-68). Conversely, 536 
it could be argued that the single cell phenotype of C. auris exhibits a level of 537 
immune evasion (as postulated elsewhere (16, 69)), which may explain the lack of 538 
response by the host to this phenotype. Future studies must continue to investigate 539 
the unique Agg phenotype of C. auris to fully clarify the organisms’ pathogenic 540 
mechanisms. These investigations must consider interactions between C. auris and 541 
other organisms that comprise the skin and/or wound microbiomes, which may 542 
function as important beacons for host invasion of C. auris.  543 
The identification of five geographically and phylogenetically distinct clades of C. 544 
auris (2, 9), containing isolates capable of forming aggregates with enhanced drug 545 
resistance, has meant that unravelling the pathogenic mechanisms employed by C. 546 
auris in vitro and in vivo remains extremely difficult. This study has highlighted 547 
different pathogenic signatures of Agg and non-Agg forms of C. auris in biofilms and 548 
during host invasion in vitro, albeit with other one isolate from each phenotypic 549 
group. Of course, given the level of heterogeneity amongst isolates, in-depth 550 
analyses from this work are limited to one Agg and one-Agg isolate. At this juncture it 551 
is unknown whether other isolates behave in a similar manner to those two 552 
described in this study, and this warrants further consideration moving forward. The 553 
level of heterogeneity observed amongst isolates in regards to the non-Agg/Agg 554 
phenotype may arise from different unique transcriptional responses between the 555 
groups. As such, future studies must continue to investigate these unique phenotypic 556 
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traits of different Agg and non-Agg isolates of C. auris from different clades to fully 557 
understand the persistence of this nosocomial pathogen in the healthcare 558 
environment, and whether such traits are comparable amongst the diverse isolates.   559 
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Table 1 – Candida auris isolates used in this study. All isolates used in the 784 
preliminary experiments in this study (as seen in Figure 1). The aggregative 785 
phenotype and clades for each isolate is also shown. * denotes the two isolates 786 
(NCPF 8973 and NCPF 8978) selected for transcriptional analyses and co-culture 787 
experiments.  788 
Figure legends 789 
Figure 1 – Schematic diagram depicting the experimental set up for the three-790 
dimensional co culture of skin epidermis and Candida auris. A 17- day mature 791 
reconstructed human epidermis (RHE) on 0.5 cm2 inserts was purchased from 792 
Episkin (Skin Ethic™). Inserts were carefully lowered into 24- well plates containing 793 
maintenance media supplied by the company (panel A). To assess the host 794 
response to aggregative and non-aggregative C. auris, control and wounded tissue 795 
was co-cultured with both isolates (NCPF 8973 and NCPF 8978) (panel B). A total of 796 
2 x 106 fungal cells in 100 µL PBS was added to the tissue and incubated overnight 797 
at 37oC, 5% CO2. For some tissues, prior to addition of fungal inoculum, three 798 
scratch wounds were induced using a sterile 19 G needle across the surface of the 799 
tissue. For visual representation of phenotype, scanning electron microscopy images 800 
included in panel B from 24 h biofilms, clearly showing the differences in cellular 801 
phenotypes between the two C. auris isolates. These images were taken at x 1000 802 
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magnification as viewed under a JEOL JSM-6400 scanning electron microscope 803 
(samples processed as previously described (70)).   804 
Figure 2 – Non-aggregative and aggregative Candida auris biofilm 805 
heterogeneity.  Biomass and impedance measurements were used as measures of 806 
biofilm formation of 26 isolates of C. auris (n=14 for non-aggregative and n=12 for 807 
aggregative phenotype). For biomass assessment, 1 x 106 fungal cells were seeded 808 
in 96-well plates and biofilm developed for 4 h or 24 h prior to crystal violet staining. 809 
Panels A and B show the differences in absorbance at 570nm of the non-810 
aggregative and aggregative, at 4 h and 24 h, respectively. The heatmap shows the 811 
average absorbance at 570nm for each individual isolate at both timepoints (C and 812 
D). The formation of C. auris biofilms in real time was monitored using electron 813 
impedance measurements on the xCELLigence real time cell analyser. Electron 814 
impedance measurements are presented as cell index for all isolates, for biofilms 815 
developed for 4 h and 24 h, respectively (E and F). The heatmap depicts the mean 816 
cell index values for all non-aggregative (G) and aggregative (H) isolates. Red data 817 
points indicate the two isolates selected for further analyses in this study (NCPF 818 
8973 and NCPF 8978). Paired Student’s t-tests were used for statistical analyses 819 
and significance between data determined at * p < 0.05 (** p < 0.01, *** p < 0.001, 820 
**** p < 0.0001).  821 
Figure 3 – Transcriptional profile of non-aggregative and aggregative Candida 822 
auris during biofilm formation. RNA from planktonic cells and biofilms formed for 823 
24 h of two isolates (NCPF 8973 and NCPF 8978) was used for RNA sequencing 824 
and transcriptome analyses as described in the text. Venn diagrams in panels A and 825 
B depict up-regulated genes in non-aggregative (A) or aggregative (B) phenotype in 826 
either planktonic form (blue circle), biofilm form (red circle) or in both forms (blue and 827 
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red circle). In panels C and D, gene distribution of significantly upregulated genes in 828 
biofilm forms were grouped for gene ontology analysis. Genes upregulated that 829 
belong to the functional pathway cellular components (CC) are shown, whilst the 830 
other two pathways (biological processes (BP) and metabolic functions (MF), 831 
respectively) are included in supplementary Figure 2. A cut-off of 2-fold up-regulation 832 
was used for gene ontology analysis using an adjusted P value of < 0.05. 833 
Figure 4 – Cytotoxic and inflammatory effects of aggregative and non-834 
aggregative Candida auris on skin epithelial models in vitro. For these analyses, 835 
a two- and three-dimensional skin epithelial model was used as schematically 836 
described in Figure 1. Firstly, cytotoxicity in the models were determined by 837 
quantifying the amount of lactate dehydrogenase (LDH) released by the human adult 838 
epidermal keratinocytes (HEKa) (A) and skin epidermis (B) following co-culture with 839 
the aggregative (NCPF 8978) and non-aggregative (NCPF 8973) isolates of C. auris. 840 
For this, data was presented as fold change relative to PBS control. To study the 841 
host response to C. auris, a RT2 profiler array containing genes associated with 842 
inflammation and fungal recognition was utilised to assess the transcriptional profile 843 
of the skin epidermis following stimulation (C). Data in the heatmap presented as 844 
Log2 fold change relative to PBS control. Finally, expression of two virulence genes, 845 
ALS5 and SAP5 was determined in the isolates infected on the tissue, values 846 
presented as % expression relative to the fungal specific house-keeping gene, β-847 
actin (D and E). All epithelial cells or tissues were infected in triplicate and statistical 848 
significance determined from raw data CT values using unpaired Student’s t-tests for 849 
comparison of two variables or one-way ANOVA with Tukey’s multiple comparison 850 
post-test for more than two variables (* p < 0.05, ** and §§ p < 0.01, *** p < 0.001, 851 













Supplementary Figure Legends 863 
Supplementary Figure 1 – Candida auris heterogeneity between isolates. 864 
Biomass and impedance measurements for 26 isolates of C. auris (n=14 for non-865 
aggregative and n=12 for aggregative phenotype) are shown as described in Figure 866 
2. Panels A and B depict the biomass of the isolates determined using crystal violet 867 
staining of 4 h (A) and 24 h (B) biofilms. Electron impedance measurements are 868 
presented as cell index values for all isolates, for biofilms developed for 4 h (C) and 869 
24 h (D). Red data points indicate the two isolates selected for further analyses in 870 
this study (NCPF 8973 and NCPF 8978). No statistical significance was observed in 871 
the data (p > 0.05).  872 
Supplementary Figure 2 – transcriptional profiles of aggregative and non-873 
aggregative Candida auris. Functional annotation of upregulated C. auris genes in 874 
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24 h biofilms of NCPF 8978 (A) and NCPF 8973 (B) isolates are shown, grouped into 875 
biological process (BP), cellular component (CC), and metabolic function (MF) gene 876 
ontology categories. Log2 fold change of genes associated with cell wall components 877 
upregulated in aggregative biofilms are shown in panel C. A cut-off of 2-fold up-878 
regulation was used for gene ontology analysis using an adjusted P value of < 0.05.  879 
Supplementary Figure 3 – Histological features of the three-dimensional skin 880 
epidermis with and without Candida auris infection. Reconstructed human 881 
epidermis (RHE) was inoculated with PBS only (A), non-aggregative (non-Agg) C. 882 
auris NCPF 8973 (B) or aggregative (Agg) C. auris NCPF 8978 (C) for 24 hours at 883 
37oC, 5% CO2. Following incubation, tissues were fixed in 10% formalin then 884 
processed for histology. Haematoxylin and eosin stains were used to assess the 885 
histological properties of the skin epidermis, showing the tissue formed a multi-886 
layered structure with keratinised peripheral cell layer (left panels). The fungal 887 
specific Periodic acid-Schiff (PAS) reagents were used to identify the fungal cells in 888 
the tissue. These were counter-stained with haematoxylin (right panels). The PAS 889 
staining depicts attachment of the fungal cells to the keratin layer, as indicated by the 890 
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